GCP
PJP icon

GSA Capital Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History

GSA Capital Partners’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Sell
3,108
-336
-10% -$36.4K 0.02% 1192
2026
Q1 		$357K Buy
3,444
+778
+29% +$82.2K 0.02% 1140
2025
Q4 		$279K Buy
+2,666
New +$268K 0.02% 1211
2024
Q2 		– Sell
-2,669
Closed -$214K – 1945
2024
Q1 		$214K Buy
+2,669
New +$207K 0.02% 1385

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

GSA Capital Partners's PJP Position: Q2 2026 in Review

GSA Capital Partners reduced its Invesco Pharmaceuticals ETF (PJP) stake by 9.8% in Q2 2026, selling an estimated $36.4K and leaving 3,108 shares worth $368K. The position accounts for 0.02% of the portfolio, ranked #1192.

GSA Capital Partners first reported a position in PJP in Q1 2024 and has held it in 4 quarters since. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • GSA Capital Partners held 3,108 shares of Invesco Pharmaceuticals ETF worth $368K as of Q2 2026.
  • GSA Capital Partners sold 336 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $36.4K.
  • Invesco Pharmaceuticals ETF made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1192 holding.
  • GSA Capital Partners first reported a position in Invesco Pharmaceuticals ETF in Q1 2024 and has held it in 4 quarters since.
  • 116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.